Flow cytometry analyzes cells to diagnose and track diseases

Flow cytometry is an advanced diagnostic laboratory technique that characterizes thousands to millions of individual cells within minutes, making it useful for diseases defined by abnormal cell populations and measurable residual disease.

In Plain English: The Clinical Takeaway

  • Cellular Sorting: Flow cytometry uses lasers and fluorescent tags to analyze physical and chemical properties of individual cells in fluid suspensions.
  • Gating Precision: Accurate interpretation relies on proper “gating”—isolating specific cell populations—to avoid misleading percentage calculations.
  • Targeted Panels: Specialized panels range from initial screening tubes to minimal residual disease assays.

How Flow Cytometry Instruments Analyze Cellular Suspensions

The diagnostic process begins when patient specimens—including blood, bone marrow, lymph node, cerebrospinal fluid, or another specimen—are suspended in fluid and passed individually through one or more lasers. The instrument records two primary categories of data to differentiate cell types: light scatter and fluorescence. Forward scatter roughly correlates with cell size, while side scatter reflects internal complexity or granularity. Together, these physical properties help laboratory specialists separate lymphocytes, monocytes, granulocytes, blasts, and debris.

Fluorescence provides the immunophenotype of each cell. Prior to analysis, the cell suspension is incubated with targeted antibodies directed against selected cellular antigens, with each antibody linked to a fluorochrome. As labeled cells pass through the laser, the fluorochromes emit light at characteristic wavelengths. Detectors capture these signals and convert them into electronic data. Modern multiparameter flow cytometry measures many antigens on the same cell at the same time, enabling clinicians to evaluate complex marker co-expression on a single cell.

Understanding Gating and Marker Interpretation Protocols

Because clinical specimens contain many different cells, laboratory specialists use a process called gating to define the population that will be analyzed. An initial gate frequently utilizes CD45 and side scatter to isolate broad leukocyte populations. Subsequent marker combinations progressively define the cells of interest. Without proper gating, clinicians risk interpretive errors, such as reading percentages without asking what the denominator is.

The clinical significance of specific Cluster of Differentiation (CD) markers depends entirely on the cellular context. For example, the expression of CD5 on T cells is normal. However, discovering CD5 on a clonal B-cell population raises a differential, particularly chronic lymphocytic leukemia/small lymphocytic lymphoma and mantle cell lymphoma. Diagnostic accuracy stems from recognizing these patterns rather than relying on a simple list of positive or negative CD markers.

Tailoring Diagnostic Panels for Acute Leukemia and Mature Neoplasms

Laboratories deploy specific panels depending on the clinical question. A screening or orientation panel determines what kind of abnormal population is present and guides subsequent testing. For instance, the EuroFlow Acute Leukemia Orientation Tube utilizes a compact combination of markers to distinguish major differentiation pathways. Diagnostic characterization panels follow, employing additional markers to define phenotypes and narrow differential diagnoses.

In acute leukemia, flow cytometry isolates immature blast populations characterized by markers like CD34, CD117, TdT, and HLA-DR. Leukemic blasts frequently exhibit aberrant antigen expression, such as AML aberrantly expressing CD7 or CD19, though lineage-associated criteria govern final classification. Once lineage is established, secondary panels narrow in on specific subsets, such as myeloid combinations (CD13, CD33, CD117, myeloperoxidase) or B-ALL phenotypes (CD19, CD22, CD79a). For mature B-cell neoplasms, surface κ and λ light chains are evaluated to establish clonality.

Consult a Doctor

Flow cytometry itself is a laboratory assay performed on tissue or fluid samples ordered by a physician. Individuals experiencing concerns regarding abnormal blood results should consult a physician for comprehensive diagnostic evaluation.

Using flow cytometry to detect abnormal plasma cells in MGUS & predict disease progression

Disclaimer: This article is for informational purposes only and does not constitute formal medical advice, diagnosis, or treatment planning. Always consult a qualified healthcare professional for medical concerns.

Photo of author

Priya Deshmukh - Senior Editor, Health

Priya Deshmukh Senior Editor, Health Deshmukh is a practicing physician and renowned medical journalist, honored for her investigative reporting on public health. She is dedicated to delivering accurate, evidence-based coverage on health, wellness, and medical innovations.

Manchester City face 30% star player value loss if sanctioned